Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials

By Machado Márcio   Iskedjian Michael   Ruiz Inés   Einarson Thomas R.  

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1825-1837

Informa Healthcare

Access to resources Recommend Favorite

Antidepressant Response and Well-Being in Pre-, Peri- and Postmenopausal Women with Major Depressive Disorder Treated with Fluoxetine

By  

Psychotherapy and Psychosomatics, Vol. 74, Iss. 6, 2005-10 ,pp. : 362-365

Karger

Access to resources Recommend Favorite

Predictors of remission with placebo using an integrated study database from patients with major depressive disorder

By Nelson J.C.   Zhang Q.   Deberdt W.   Marangell L.B.   Karamustafalioglu O.   Lipkovich I.A.  

Current Medical Research and Opinion, Vol. 28, Iss. 3, 2012-03 ,pp. : 325-334

Informa Healthcare

Access to resources Recommend Favorite

Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study

By Nierenberg Andrew A.   Greist John H.   Mallinckrodt Craig H.   Prakash Apurva   Sambunaris Angelo   Tollefson Gary D.   Wohlreich Madelaine M.  

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 401-416

Informa Healthcare

Access to resources Recommend Favorite

Antidepressant Dose Reduction and the Risk of Relapse in Major Depressive Disorder

By  

Psychotherapy and Psychosomatics, Vol. 76, Iss. 5, 2007-08 ,pp. : 266-270

Karger

Access to resources Recommend Favorite